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Abstract
Influenza and respiratory syncytial virus (RSV) are the leading etiological agents
of seasonal acute respiratory infections (ARI) around the world. Medical doctors
typically base the diagnosis of ARI on patients’ symptoms alone, and do not always
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conduct virological tests necessary to identify individual viruses, which limits the
ability to study the interaction between multiple pathogens and make public health
recommendations. We consider a stochastic kinetic model (SKM) for two interacting
ARI pathogens circulating in a large population and an empirically motivated background
process for infections with other pathogens causing similar symptoms. An extended
marginal sampling approach based on the Linear Noise Approximation to the SKM
integrates multiple data sources and additional model components. We infer the
parameters defining the pathogens’ dynamics and interaction within a Bayesian hierarchical
model and explore the posterior trajectories of infections for each illness based on
aggregate infection reports from six epidemic seasons collected by the state health
department, and a subset of virological tests from a sentinel program at a general
hospital in San Luis Potos´ı, Me´xico. We interpret the results based on real and
simulated data and make recommendations for future data collection strategies. Supplementary
materials and software are provided online.
Keywords: Acute respiratory disease, Bayesian hierarchical modeling, Linear noise approximation,
Influenza, Respiratory syncytial virus
1 INTRODUCTION
Inference on mathematical models of epidemic dynamics has become a powerful tool in
the prediction, assessment, and control of disease outbreaks (Star and Moghadas 2010;
Huppert and Katriel 2013; Siettos and Russo 2013). Such models are predominantly
stochastic, reflecting the random nature of a large number of human interactions which
enable infections to spread and individuals to change their infection status. The probabilities
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of discrete transitions from one infection state to another are defined up to a set of unknown
parameters, which may be inferred from observed data. The most widely used models
are variations on the “Susceptible-(Exposed-)Infected-Recovered” (SIR/SEIR) formulation,
which describes the temporal evolution of the proportion of individuals in each infection
state at a given time. A variety of strategies have been developed to incorporate process-specific
demographic stochasticity in this compartmental model. For example, Dukic et al. (2012)
model process stochasticity by an additive white noise process on the growth rate of the
infectious population computed from states that evolve according to the deterministic
compartmental dynamics described above. In a different approach, Farah et al. (2014)
assume additive process noise on the infection states of a deterministic SEIR model.
Another approach is taken by Shrestha et al. (2011) by modeling infection state counts
as multinomial processes with probabilities of inclusion obtained by first solving the ODE
corresponding to the compartmental model and then solving for the transition probabilities
as functions of current states. Another popular class of models, considered in this paper,
describes process noise by modeling each individual interaction directly. This approach is
based on stochastic kinetic modeling (e.g., Wilkinson (2006)), a first-principles interpretation
of SIR dynamics inspired by chemical mass-action kinetics where molecules interact and
change state according to specified transition probabilities. This approach accurately
reflects inherent stochasticity in infection states because it naturally models individual-level
transitions from one infection state to another as stochastic processes incorporating assumptions
about both the disease and the interactions. However, estimation for such models poses
a unique set of challenges. For a small population or one where state transitions can
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be observed directly, posterior inference on the SKM parameters can exploit closed form
expressions for full conditional distributions (Boys et al. 2008; Choi and Rempala 2011),
but even for moderately sized populations, individual interactions and transitions become
increasingly difficult to simulate and marginalize over. Furthermore, since data typically
consists of observed infection counts rather than individual transition times, computation of
the likelihood becomes computationally infeasible. To resolve this issue, a common strategy
is to construct the likelihood based on a large-volume limit via diffusion approximation of
the SKM (Van Kampen 1992), also known as the Linear Noise Approximation (LNA).
Inference for model parameters based on this approximation was conducted in work by
Komorowski et al. (2009); Golightly and Wilkinson (2011); Fearnhead et al. (2014); Golightly
et al. (2015). However, challenges still remain in applying this approach to realistic
data scenarios, such as conditioning on multiple data types that depend on the unknown
infection states, and introducing model components to describe unmodeled disease states
or account for model discrepancy. The contribution of the present work is to address these
challenges by generalizing the approach of Fearnhead et al. (2014), which allows us to
address the motivating problem of inference on the dynamics of two interacting pathogens
from both aggregated infection reports and a subset of virological data collected in the
state of San Luis Potos´ı, Me´xico. The ability to utilize multiple data sources allows
estimation of parameters involved in the interaction of different pathogens that cause
similar symptoms. Indeed, to our knowledge, our approach is the first to directly recover
cross-interference parameters in a SKM for two pathogens as part of an overall hierarchical
Bayesian inferential framework. We additionally identify and address practical challenges
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of working with such models, including posterior sampling strategies that are well suited
to such situations.
The article is organized as follows. The motivating application and the data are
described in detail in Section 2. Section 3 begins by constructing a SKM for the evolution
of individual infection states of the acute respiratory pathogens influenza and RSV and
then describes its limiting behaviour in the large-population limit. A Bayesian hierarchical
model is then formulated relating aggregated infection counts and a subset of virological
tests to the SKM for infection states of the two pathogens augmented by a background
model component representing infection by other pathogens. The inferential strategy
is described in Section 4. Section 5 describes the results of the analysis based on six
years of real and simulated data and provides a discussion of identifiability in the context
of the multi-pathogen problem, using simulation to shed light on model identification
under two data availability scenarios. Finally, Section 6 discusses the feasibility of our
approach, summarizes our findings, and offers some perspectives on future work. Software
to reproduce all results is provided at github.com/ochkrebtii/Multipathogen-ARI-dynamics
(upon publication).
2 MOTIVATING APPLICATION
ARI are infections of the upper and lower respiratory tract caused by multiple etiological
agents, most frequently, adenovirus, influenza A and B, parainfluenza, RSV, and rhinovirus.
An important public health concern around the world, ARIs are responsible for substantial
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mortality and morbidity (Thompson et al. 2003; Troeger et al. 2018), mainly affecting
children under 5 and adults over 65 years of age (Kuri-Morales et al. 2006). Understanding
of the underlying mechanisms of spread, transmission, and, importantly, cross-interference
between these pathogens aids policy makers in assessing public health strategies and
decision-making (Huppert and Katriel 2013).
Although different viruses are responsible for ARI, a substantial part of the burden of
ARI in most regions is due to influenza and RSV (Chan et al. 2014; Velasco-Herna´ndez
et al. 2015; Chaw et al. 2016). The interaction and temporal dynamics of these pathogens
are complex. Evidence suggests that influenza and RSV are seasonally related (Mangtani
et al. 2006; Bloom-Feshbach et al. 2013) and circulate at similar times of the year in some
temperate zones (Bloom-Feshbach et al. 2013; Velasco-Herna´ndez et al. 2015). Because
of their interaction and interference, these infections do not usually reach their epidemic
peaks simultaneously (A˚nestad 1987; Anestad et al. 1982; Anestad and Nordbo 2009), with
peak times typically differing by less than one month (Bloom-Feshbach et al. 2013). In the
clinical setting, it is difficult to determine which pathogen may be responsible for a patient’s
ARI, because of their overlapping circulation times and similar symptoms. Furthermore,
laboratory tests necessary for identification of the virus are not conducted in most patients
(Chan et al. 2014).
Our analysis is based on data from epidemic seasons 2003-2004 through 2008-2009,
beginning in the first week of August and ending in the last week of July of the following
year. Specifically, we use data on weekly aggregated morbidity reports and virological time
series obtained in the state of San Luis Potos´ı, Me´xico. Morbidity reports consist of weekly
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reports of ARI that required medical attention1 at all community clinics and hospitals
in the state that were reported to the State Health Service Epidemiology Department.
The virological data was obtained from records of the Virology Laboratory (Facultad de
Medicina, UASLP, San Luis Potos´ı, Me´xico) and consists of weekly counts of positive tests
for RSV and influenza as well as tests which were negative for both pathogens. These
virological tests were performed on all eligible pediatric patients (children under 5 years of
age) admitted with lower respiratory infections (Go´mez-Villa et al. 2017; Vizcarra-Ugalde
et al. 2016) to Hospital Central “Dr. Ignacio Morones Prieto”. Available data indicate
that when these viruses present in community outbreaks, they tend to affect all age groups
at the same time. Although the precise time of influenza epidemic onset and peak may
vary slightly between age groups, influenza outbreaks tend to be synchronized across age
groups (Wu et al. 2016). In addition, influenza surveillance data, such as that reported
from Australia in 2017, shows similar influenza epidemic curves across different age groups
(Australian Government Department of Health 2017). Detailed transmission studies show
that RSV cases frequently present around the same time in different age groups within
a household (Munywoki et al. 2013). Additionally, these virological tests are unlikely to
reflect only small-scale outbreaks, since Hospital Central “Dr. Ignacio Morones Prieto”
admits patients from all regions of the state. Though the number of virological tests is
small relative to the total number of aggregated ARI reports, the systematic sampling of
patients year-round, irrespective of the identification of an epidemic by any given virus,
provides information on the period of circulation of influenza and RSV.
1This category includes all cases corresponding to the International Classification of Disease, 10th review
(ICD-10) codes: J00-J06, J20, J21, except J02.0 and J03.0
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3 MODELING
This section describes a SKM of influenza and RSV dynamics, as well as its diffusion
approximation in the large-population limit, required to compute the likelihood of reported
infection data and virological tests. We then construct a Bayesian hierarchical model
that relates the governing equations, including a background infection component, to the
aggregated ARI reports and the virological tests.
3.1 Stochastic Kinetic Model of a two-Pathogen System
Stochasticity is inherent in biological systems due to their discrete nature and the occurrence
of environmental and demographic events. In the case of disease dynamics, the occurrence
of events such as interactions between individuals that constitute exposure can be reasonably
described as stochastic. Therefore it is reasonable to model this stochasticity directly in
the individual transitions, in contrast to indirectly modeling their aggregate behavior or
perturbing a deterministic compartmental model. Stochastic Kinetic or Chemical Master
Equation modeling (Allen 2008; Wilkinson 2011) is a mathematical formulation of Markovian
stochastic processes which describe the evolution of the probability distribution of finding
the system in a given state at a specified time (Gillespie 2007; Thomas et al. 2012).
To model the relationship between influenza and RSV (henceforward called pathogens 1
and 2 respectively) during a single year, we consider a closed population of size Ω, assumed
to be well mixed and homogeneously distributed, where the individuals interacting in a fixed
region can make any ofR possible transitions. The stochastic “Susceptible-Infected-Recovered”
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Figure 1: SIR model with two pathogens. Xkl represents the number of individuals in immunological
status k for pathogen 1 and status l for pathogen 2. Labels above the arrows represent the reaction rates
for each reaction type.
(SIR) model with two pathogens (Kamo and Sasaki 2002; Adams and Boots 2007; Vasco
et al. 2007) is described by eight compartments corresponding to distinct immunological
statuses. Denote by Xkl(t) the number of individuals at time t in immunological status
k ∈ {S, I, R} for pathogen 1 and immunological status l ∈ {S, I, R} for pathogen 2. We
omit the state XII from the model because, although simultaneous infection by both viruses
is biologically possible, clinical studies have found that the frequency of co-infection with
RSV and influenza is usually low (Meskill et al. 2017).
In our model, the constants β1 and β2 represent the contact transmission rate, which
describes the flow of individuals from the susceptible group to a group infected with
pathogen 1 and 2 respectively. In the context of ARI, the average recovery time is known
9
to be relatively stable and lasts for approximately 7 days (Centers for Disease Control
and Prevention 2008). Therefore, the rate, γ, at which infected individuals recover (move
from infected to temporary immunity in the recovered category) is 1/7 days−1. Since the
population is relatively stable over the years under study, we set the birth rate equal to
the death rate µ in our transition model. We also assume an average life expectancy of
1/µ = 70 years−1 (World Health Organization 2017). Variables λ1 and λ2 represent the
proportion of the population infected with pathogens 1 and 2 respectively at a given time.
Finally, to describe the interaction between influenza and RSV, we use the cross-immunity
or cross-enhancement parameters σ1 and σ2. Cross-immunity for influenza is present when
0 < σ1 < 1, indicating that the presence of RSV inhibits infection with influenza. A value
of σ1 = 0 confers complete protection against influenza while a value of σ1 = 1 confers
no protection; and a value of σ1 > 1 represents increasing degree of cross-enhancement,
indicating that the presence of RSV enhances the presence influenza (Adams and Boots
2007). The definition of σ2 is analogous. Further customization of the transition mechanism
is possible within this stochastic dynamical model (e.g. Wilkinson 2006), and is desirable
when additional information about the system dynamics is available. Examples include
considering the effect of vaccination programs, seasonal forcing, or the presence of specific
additional pathogens in circulation. We discuss these in the section on future work.
We next make the following standard assumptions on the infection states X. Transitions
from one state to another depend only on the time interval but not on absolute time,
mathematically, X(∆t)−X(0) andX(t+∆t)−X(t) are identically distributed. Additionally,
the probability of two or more transitions occurring simultaneously is assumed to be zero.
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Table 1: Parameters defining the two-pathogen SKM for influenza and RSV
Parameter Description
σ1 Cross-immunity or enhancement for pathogen 1
σ2 Cross-immunity or enhancement for pathogen 2
λp Proportion of individuals infected with pathogen p = 1, 2
βp Baseline transmission rate for pathogen p = 1, 2
µ Birth and death rate
γ Recovery rate
Ω Average yearly population size (assumed stable over time)
Since the model preserves mass, the constraint Ω = XSS + XIS + XSR + XRS + XSI +
XRR +XRI +XIR is satisfied. The probability mass function pt describing the probability
of being in state X = x at time t evolves according to the Kolmogorov forward equation
(chemical master equation, or CME),
dpt(x)
dt
=
R∑
j=1
{aj(x− vj)pt(x− vj)− aj(x)pt(x)} , (1)
where the transition probabilities aj(x) are obtained by multiplying the rates shown in
Figure 1 by ∆t sufficiently small (Gillespie 2007; Allen 2008), and vj(t) are stoichiometric
vectors whose elements in {−1, 0, 1} describe the addition or subtraction of mass from a
particular compartment. A list with theR reactions and the explicit form of these terms are
defined in the Supplement. The large-volume approximation to this system characterizes
the distribution of the Markov process X(t), t ∈ [0, T ] as,
X(t) | θ ∼ N
(
Ωφ(t) + Ω1/2ξ˜(t),ΩC(t, t)
)
, t ∈ [0, T ]. (2)
The next section defines the quantities φ, ξ˜, C, and explains the above large-volume approximation.
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Readers who are familiar with the details of the approximation may skip this section.
Section 3.3 describes how this approximation is used to model aggregated report data.
3.2 Model Components via Linear Noise Approximation
A large-volume approximation of the CME (1) is given by the van Kampen expansion,
which can then be computed via the Linear Noise Approximation (LNA) (Van Kampen
1992). For large Ω the system states X can be expressed as the sum of a deterministic
term φ : [0, T ]→ R+S and a stochastic term ξ,
X(t) = Ωφ(t) + Ω1/2ξ(t), t ∈ [0, T ]. (3)
Assuming constant average concentration, the size of the stochastic component will increase
as the square root of population size. Let S = [v1, . . . , vR] be a dim{X(t)}×R stoichiometric
matrix that describes changes in the population size due to each of the R reactions. The
time-evolution of the term of order Ω1/2 (Van Kampen 1992), φi(t) = limΩ,X−→∞Xi(t)/Ω
is governed by the ODE initial value problem,

dφi(t)
dt
=
R∑
j=1
Sijaj(φ(t)), t ∈ (0, T ], i = 1, . . . , dim{X(t)},
φi(0) = φ0, i = 1, . . . , dim{X(t)}.
(4)
12
where φ0 = X(0)/Ω. The stochastic process ξ is governed by the Itoˆ diffusion equation,
dξ(t) = A(t)ξ(t)dt+
√
B(t)dW (t), t ∈ [0, T ], (5)
where A(t) =
∂S a(φ(t))
∂φ(t)
, B(t) = S diag{a(φ(t))}S>, and W (t) denotes the R dimensional
Wiener process (Van Kampen 1992; Gillespie 2007). For fixed or Gaussian initial conditions,
the SDE in (5) can be solved analytically. The solution of this equation is a Gaussian process
with mean ξ˜ and covariance C (Van Kampen 1992), that is,
ξ(t) ∼ N
(
ξ˜ (t) , C(t, t)
)
, t ∈ [0, T ], (6)
where ξ˜(t) and C(t, t) are obtained (see Van Kampen (1992), pp. 210-214) by solving the
ODE initial value problem,

∂ξ˜(t)
∂t
= Φ(t)ξ˜(0), t ∈ (0, T ],
ξ(0) = ξ˜0,
(7)
where Φ(t) is the evolution, or fundamental matrix (Grimshaw 1991) determined by the
matrix equation, 
Φ˙(t) = A(t)Φ(t), t ∈ (0, T ],
Φ(0) = I.
(8)
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The covariance C is obtained by solving,

dC(t)
dt
= C(t)A(t)T + A(t)C(t) +B(t), t ∈ (0, T ],
C(0) = C0.
(9)
It follows from (3) and (6) that the transition densities of X(t) are given by (2).
3.3 Probability Models for Aggregate Reports and Virological
Tests
Our first data set consists of indirect observations of the Markov process X(t) : t ∈ [0, T ]
transformed via GT = [0, 1, 0, 1, 1, 0, 1, 0]. That is, observations are made on the total
number G>X = XIS(t) + XIR(t) + XSI(t) + XRI(t) of reported infections from influenza
and RSV. Setting ξ˜(0) = 0, it follows that ξ˜(t) = 0 for all t ∈ [0, T ]. Thus,
G>X(ti) | θ ∼ N
(
ΩG>φ(ti), ΩG>C(ti)G
)
, i = 1, . . . ,M, (10)
where θ is a vector of the SKM parameters defined in Section 3.1, augmented with unknown
initial conditions for X and prior variance on the state, C0 = c0Idim(X),dim(X),
θ = [β1, β2, σ1, σ2, X(0), C0]. (11)
The aggregate number of ARI cases in the San Luis Potos´ı data also includes infections
by viruses other than influenza and RSV. Although these may be responsible for a significant
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fraction of all ARI cases, influenza and RSV are the two viruses that drive the epidemic
fluctuations observed during the winter outbreaks in each year. Other viruses in circulation
are included in the model by augmenting the state vector X by a background term
corresponding to ARI infection that is not caused by Influenza or RSV. In contrast to
infection states by Influenza or RSV, this background term is modelled empirically rather
than mechanistically. It is reasonable to assume that the number of background infections
during a given week is related to the previous week’s up to process noise. This implies the
autoregressive model,
D(ti) = Ωc+ νD(ti−1) + η(ti), i = 1, . . . ,M, (12)
where |ν| < 1 and η(ti) ∼ N
(
0,Ω3/2κ
)
, i = 1, . . . ,M are independent, zero-mean, stochastic
terms. The order of the process noise was chosen to be between that of X (proportional to
Ω) and of the observation error (proportional to Ω2). This choice results in a background
process that is more variable than the state X but is not flexible enough to over-fit the
data. Moreover, to ensure comparable spread, we set κ = c0, the prior process variance for
the infection states X. As with any model discrepancy term, the integration of additional
data or information (in our case, the results of virological tests) will help to constrain the
background model (Brynjarsdo´ttir and O’Hagan 2014).
Observed aggregate counts are assumed subject to independent Normal observation
errors with mean zero and variance Ω2Σ. We make the additional assumption that a fixed
proportion, r ∈ [0, 1], of all individuals infected with ARI seek consultation. Therefore, the
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likelihood of the observed aggregated reports is,
Y (ti) | φ(ti), C(ti), θ, τ
∼ N (rΩG>φ(ti) + rΩc/(1− ν), r2ΩGTC(ti)G+ r2Ω3/2κ/(1− ν2) + Ω2Σ) , i = 1, . . . ,M,
(13)
where τ is a vector containing auxiliary parameters not directly related to the SKM defined
in Section 3.1,
τ = [c, ν, r,Σ].
The justification for modeling the total number of influenza and RSV infections directly
via the Normal model obtained via the LNA is computational (Fearnhead et al. 2014;
Golightly et al. 2015), by exploiting the availability of closed-form Bayesian updates over
the states. Modeling counts via a discrete distribution centered at the LNA would require
an additional layer of sampling at each observation location for each Markov chain Monte
Carlo (MCMC) iteration, which would quickly become computationally infeasible.
Simulation results in Section 5.3 suggest that using aggregate counts (13) alone leaves
some uncertainty about the circulation patterns of individual pathogen infection trajectories,
and that the inclusion of the virological data described in Section 2 can aid in disaggregating
the dynamics of the two pathogens. Denote by N1(ti), N2(ti), N3(ti) the number of
virological laboratory tests that identified influenza, RSV, and neither pathogen, respectively,
for children under 5 years of age admitted with an ARI during week i at Hospital Central.
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The total number of virological tests is related to the number of infected individuals in
the population as follows. According to the 2010 census, there were Ωc = 266, 761 children
under 5 years of age in San Luis Potos´ı out of a total population of Ω = 2, 585, 518 (Consejo
Nacional de Poblacio´n, Me´xico). Furthermore, available data suggests that approximately
rh = 0.0005 of children with reported ARI in the state are admitted to Hospital Central,
and are therefore eligible for a virological test. Thus, we model the expected number of
virological tests that were positive for influenza, RSV, and other background infections,
respectively as,
mN1(ti) = E (N1(ti) | X(ti), θ, τ) = rhr(Ωc/Ω) (XIS(ti) +XIR(ti)) , i = 1, . . . ,M,
mN2(ti) = E (N2(ti) | X(ti), θ, τ) = rhr(Ωc/Ω) (XSI(ti) +XRI(ti)) , i = 1, . . . ,M,
mN3(ti) = E (N3(ti) | X(ti), D(ti), θ, τ) = rhr(Ωc/Ω)D(ti), i = 1, . . . ,M.
The variability in the true proportion of the infected population admitted to Hospital
Central, motivate the use of the variance-inflated model,
Nk(ti) | X(ti), D(ti)θ, τ ∼ NegBin (v mNk(ti), 1/(1 + v−1)) , k = 1, 2, 3, i = 1, . . . , T,
(14)
where v is an unknown variance inflation parameter. The variance of (14) ismk(ti) (1 + 1/v)
and is controlled by the unknown parameter v, which will be estimated along with the other
model components.
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Table 2: Parameters defining the observation and background models
Parameter Description
c AR-1 model additive constant term for the number of background infections
ν AR-1 model coefficient for the number of background infections
v Variance inflation factor for virological data
Σ Observation noise variance
r Reporting proportion for those infected with an ARI
rh Average proportion of total children with ARI admitted to the Hospital Central
Ωc Average yearly number of children under 5 years of age in San Luis Potos´ı
3.4 Prior Probability Model for Unknown Parameters
Prior distributions on the model and auxiliary parameters are obtained by expert elicitation
and by enforcing physical constraints. For example, ensuring that initial conditions on the
states represent the entire population requires that elements of the unknown initial state
vector X(0)/Ω lie on the simplex, suggesting the use of a Dirichlet prior. Parameters
that are constrained between 0 and 1, such as the reporting proportion r and the AR-1
coefficient ν for the background term, are assigned uniform prior distributions on (0, 1).
The remaining parameters are bounded below by zero, and are therefore assigned Gamma
priors. The shape and scale hyperparameters for the Gamma prior on the transmission
rates βp, p = 1, 2, are chosen to be 20 and 3, respectively to yield a reasonable prior mean
of 60 days−1 and a large spread reflecting our uncertainty about these quantities. The
shape and scale for the Gamma prior on the cross-interference parameters σp, p = 1, 2, are
chosen to be 10 and 0.1, respectively. This choice places a relatively large prior weight on
the region around the neutral case σp = 1, p = 1, 2. The same hyperparameters are chosen
for the variance inflation factor, so that the prior mean corresponds to a relatively small
spread in the counts of virological test data. The hyperprior on the prior variance c0 of the
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states and the prior on the error variance Σ are both Gamma with shape parameter 1 and
scale parameter 0.01, ensuring moderately sized prior means on the scale of the population
and substantial posterior mass near zero.
4 INFERENTIAL METHODOLOGY
4.1 Extended Marginal Sampling Approach based on LNA
In order to avoid expensive particle MCMC at each iteration of the sampling algorithm
over the model parameters, Fearnhead et al. (2014) developed an approximate marginal
approach based on Bayesian updating conditional on the partially observed state contaminated
with Normal error. Instead of sampling from p(x | θ) for each proposed value of θ using,
for example, an expensive Gillespie algorithm (Gillespie 2007), an approximate marginal
likelihood pa(y | θ) based on the LNA is obtained sequentially in closed form. This
approach results from the repeated application of forecasting and analysis steps under
a Kalman filtering framework (see Wikle and Berliner (2007) for a detailed discussion).
The approximation comes from the fact that the operator that takes the state from time
ti−1 to time ti is nonlinear for SKMs. Nevertheless, simulations by Fearnhead et al. (2014)
show that the method appears to correctly capture the model dynamics, while substantially
reducing computational cost relative to direct inference. For this reason, this and related
approximate techniques are the state of the art in the large population setting for fitting
SKMs, as exact inference is typically computationally infeasible. For our analysis, this
approach must be extended to integrate multiple data sources as well as including an
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additional model discrepancy term. The argument that allows computation of pa(y | θ) in
closed form requires Normality and so cannot be applied directly to the virological data N .
Algorithm 1 in the Appendix summarizes the extended procedure. Due to the sequential
nature of the algorithm, we use the subscript notation to denote time. For example x1:i
denotes the vector of observed infection states x at times t1 through ti. We wish to sample
from the posterior distribution over the unknown parameters and infection states. This is
proportional to the prior multiplied by the likelihood components (2), (12), (14), and the
approximate marginal likelihood pa (y1:M | θ, τ),
pia (θ, τ, x1:M , d1:M | y1:M , n1:M)
∝ p (n1:M | x1:M , d1:M , y1:M , θ, τ) p (x1:M , d1:M | y1:M , θ, τ) pa (y1:M | θ, τ) pi (θ, τ) ,
(15)
assuming conditional independence between Y andN given the infection states, background,
and parameters. The sequential application of forecast and analysis steps to obtain pa (y1:M | θ, τ),
provides the necessary information to sample from the approximate smoothing distribution
over x1:M and d1:M . This forms a likelihood-free step, conditional on which we can evaluate
the likelihood component p (n1:M | x1:M , d1:M , y1:M , θ, τ). This approach has the additional
advantage of allowing us to visualize the posterior samples over the infection states and
background, as well as to conduct one-step-ahead validation of the model by visualizing
the posterior predictive distribution at each step.
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4.2 Analysis of Multiple Years
The model formulated in Section 3 and the extended marginal sampling approach presented
in Section 4.1 can, in principle, be applied over time domains of any length. However,
in the context of our motivating problem, estimating the model for each epidemic year
separately is consistent with the understanding of the way that different strains of influenza
and RSV circulate from year to year. Parameters defining the circulation and interaction
dynamics of influenza and RSV differ from strain to strain of the virus, and different
strains of each virus circulate in different years. Specifically, RSV is classified into two
major groups, A and B, each of which contains multiple variants (Venter et al. 2001;
Mufson et al. 1988; Anderson et al. 1985). Of the five years studied by Peret et al. (1998),
each year saw a shift in the predominant genotype or subtype of RSV, so that no single
genotype or subtype was dominant for more than one of the five years. Peret et al. (1998)
hypothesized that newly introduced strains are better able to evade previously induced
immunity in the population and consequently either circulate more efficiently or are more
pathogenic. Similarly, influenza viruses continually change due to antigenic drift, which
requires vaccine reformulation before each annual epidemic (Ferguson et al. 2003), and
antigenic shift (Centers for Disease Control and Prevention 2008; Zambon et al. 2001;
Rambaut et al. 2008), which can lead to the emergence of new influenza epidemics. All
of these effects combine to create unique conditions in each epidemic year. We note that
sometimes such changes can occur within a single epidemic year, such as with the emergence
of the global influenza A (H1N1) pandemic in April 2009. As will be seen in the analysis,
the model fitted using data from the epidemic year 2008-2009 is only partially able to
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capture the dynamics of this second epidemic wave of influenza in the latter part of the
year.
5 RESULTS
This section describes the results of our analysis on both real and simulated data from San
Luis Potos´ı.
5.1 Computational implementation
Posterior sampling was conducted by embedding the extended marginal sampling algorithm
1 for the states within a parallel tempering Markov chain Monte Carlo sampler (PTMCMC,
Geyer 1991) over the unknown parameters. PTMCMC is suited to this application because
it can effectively explore challenging posterior densities, with features such as ripples and
ridges, which occurs when different combinations of parameters lead to similar model
fits. 200,000 iterations of PTMCMC were obtained for each year using 8 parallel chains
each. Due to strong posterior correlations between groups of parameters in our model,
the parameters were sampled in three distinct blocks. One block consisted of the model
parameters β1, β2, σ1, σ2. Another block consisted of prior state variance c0 and parameters
defining the observation processes, Σ, r, c, v, ν. Proposal covariance adaptation was performed
for both blocks during the first 100,000 iterations, which were then discarded as burn-in.
The last block consisted of the initial states XSS, XIS, XRS, XSI , XRI , XSR, XIR, XRR.
For this block, only the proposal variances were adapted, because both the sign and
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magnitude of posterior correlations between these quantities vary across the parameter
space. Convergence was diagnosed by visual inspection of trace plots and correlation plots.
5.2 Inference Based on Data From San Luis Potos´ı, Me´xico
We examine the results for the motivating application of inferring the dynamics of influenza
and RSV from aggregate ARI counts and auxiliary virological testing data from San Luis
Potos´ı, Me´xico. Summaries of the marginal posterior distribution over ARI reports in the
state are shown in Figures 2 and 3. Figure 3 illustrates marginal posterior summaries over
disaggregated infection states (influenza, RSV, and background), while Figure 2 aggregates
these summaries to allow for visual comparison with the data. Parameter estimates and
credible intervals are provided in the Appendix.
In all the years examined except 2005-06, a single pathogen, either influenza or RSV,
peaks first, followed by a peak associated with the other pathogen. Regardless of which
peaks first, in all six years, the posterior trajectories agree with the patterns suggested by
the virological test data. Specifically, in all years except 2003-04 and 2005-06, RSV cases
peaks first, followed by influenza, with infections subsiding by the end of the epidemic
year. In 2005-06, it appears that the first peak in aggregate infections may be due both
influenza and RSV peaking at similar times, which is also consistent with the virological
test data for that year. A secondary outbreak of RSV occurs later during that year and
may be an indication of a new outbreak caused by a different strain of the virus than
was circulating in the first half of the year. Secondary peaks that sometimes appear in
the number of infections by a given pathogen may be due to the outbreak caused by a
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different strain of that pathogen. Another possible explanation is geographical, with a
new outbreak occurring in a different region that had not previously been exposed to the
particular strain. The flexibility of our model to capture multiple epidemic peaks is useful,
and will be further considered in light of recent literature in the Discussion.
For the most part, estimates of cross-interference parameters suggest that some degree
of cross-enhancement exists between influenza and RSV, meaning that infection with one
pathogen may be enhancing the chance of infection with the other. However, infection
with the strains of RSV circulating in 2003-04 may have offered some protection against
influenza, while the reverse appears to have occurred in 2008-09. Less strong evidence for
such cross-immunity occurs for both pathogens in 2004-05, and for RSV in 2005-06, 2006-07,
and 2008-09, based on the coverage of the credible intervals over the cross-interference
parameters. The importance of enabling the estimation of cross-immunities, and consequently
disaggregating pathogen dynamics, is highlighted in the Discussion section. Our analysis
lends force to the argument that novel sentinel programs, like the one implemented at
Hospital Central, provide a powerful tool to study these epidemics.
In order to obtain more insight into our analysis, a simulation was conducted as follows.
For each year, the model parameters estimated from the real data were used to generate a
synthetic data set. First, the Gillespie algorithm (Gillespie 2007) was used to simulate a
trajectory for influenza and RSV based on the original SKM described in Section 3.1. The
background term was then simulated according to the generating model (12) and aggregate
data and virological tests were generated according to (13) and (14) respectively. An
illustration of the simulated data and posterior summaries are provided in the Supplement.
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Though it is clear that the simulated aggregated data produces similar dynamics to what
was observed in San Luis Potos´ı, Me´xico, the simulation fails to reproduce the larger spikes
in number of aggregate cases that in our model are explained by secondary peaks of a given
epidemic. A possible explanation for this phenomenon is the fact that multiple strains of
each pathogen in circulation have different characteristics, which can only be recovered
on average over a full year of real data. Therefore, simulating from this model would
produce behaviour associated with such an “average” strain. Virological data appears
to be well reproduced by the simulation model, although there may be evidence that
unmodeled temporal correlation between these data could be present. For all the years
being considered, the analysis of the simulated data yields results that were expected given
the simulation settings. In particular, the order of the pathogen peaks and their location
were correctly recovered, though the apparent overlap of peak infection for influenza with
the initial peak in RSV in year 2005-2006 was not predicted. This may be explained by the
fact that large initial epidemic peak in the real data for 2005-2006 was not reproduced in
the simulated data, so that coincident infections were not required to explain the simulated
data.
5.3 Identifiability in the Multi-pathogen Problem
In general, the ability to estimate parameters and distinguish pathogen dynamics depends
on both the model structure and the availability and type of data used to estimate them
(Huppert and Katriel 2013). Various features of this problem are known as identifiability,
and have been studied in the context of infection models. Shrestha et al. (2011) show
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Figure 2: Posterior summaries for aggregated ARI reports from San Luis Potos´ı, Me´xico. The aggregated
data, measured from August to July of the following year, is represented by black dots. Grey bands
represent point-wise 95% credible intervals and the cyan dotted line shows a maximum a-posteriori
estimated trajectory.
via simulation that likelihood-based methods can identify parameters of a multi-pathogen
system under some conditions for models where the states are defined by a Multinomial
process with expectation given by the solution of an ODE initial value problem. In a
thorough investigation of sensitivity and local identifiability for SKMs, Komorowski et al.
(2011) develop an approach to compute the Fisher Information Matrix for the model
parameters, providing a valuable tool for model diagnosis. However, this approach is
limited in our setting, because the order in which the individual epidemic trajectories
peak is closely tied to the estimated initial states, which lie on the 8-simplex. Since
traditionally used tools for diagnosing lack of identifiability are not directly applicable,
simulation under different data availability scenarios can help to illustrate the value of
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Figure 3: Posterior summaries for disaggregated reports based on data from San Luis Potos´ı, Me´xico.
Left axis: Grey bands represent 95% credible intervals for influenza (red outline), RSV (blue outline) and
background infections (green outline). Dotted lines represent maximum a-posteriori estimated trajectories.
Right axis: Reports of influenza and RSV from ARI affected children under 5 years of age at Hospital
Central, with tests positive for influenza, RSV, and neither, are shown as shaded red, blue, and green
polygons, respectively.
additional virological data in identifying which is the leading epidemic in a given season.
However, care must be taken in how these simulations are conducted, as direct comparison
by removing the likelihood component corresponding to the additional virological data also
removes the important constraint against over-fitting by the background infection model
(12). Therefore, to illustrate the sensitivity of the model to lack of information on individual
infections, we replace (12) with a linear discrepancy term to facilitate comparison. Figure
4 illustrates 25 posterior sample paths with (right panel) and without (left panel) including
the virological data in the analysis of simulated data from 2003-04. Although most of the
posterior sample paths for the model fitted using only aggregated reports point to influenza
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as the first pathogen to peak over RSV (red lines dominate blue lines in the first peak),
some uncertainty remains about their order2. On the other hand, including virological data
induces a clear preference for influenza as the first pathogen to peak, although multiple
smaller peaks for each epidemic may still be present.
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Figure 4: Left: 25 posterior sample paths over the trajectories of influenza (red) and RSV (blue) given
aggregate ARI reports only. Right: 25 posterior sample paths over the trajectories of trajectories of
influenza (red) and RSV (blue) given both the aggregated ARI reports and the virological test data. The
virological test data is reported on the right axis of the figure, with tests positive for influenza, RSV, and
neither, shown as shaded red, blue, and green polygons, respectively.
6 DISCUSSION
We have presented a Bayesian hierarchical model based on stochastic kinetic dynamics for
two pathogens with similar symptoms and have extended the marginal sampling approach
of Fearnhead et al. (2014) to integrate multiple data sources and include an empirically
based discrepancy model representing infections with other pathogens. We found that
the inclusion of the additional virological data allowed us to recover cross-interference
parameters and to disaggregate the trajectories of individual pathogens. Our approach is
2This also highlights the importance of using population based sampling methods, such as Parallel
Tempering MCMC, to enable exploration of multiple posterior modes.
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general and can be applied to the problem of inference on stochastic kinetic models, as well
as models of more than two interacting epidemics, when enough data is available to recover
their individual dynamics.
Simulations suggest that our approach correctly recovers cross-immunities and the
order and location of epidemic peaks of influenza and RSV in a given epidemic year.
This is important because of the central role that cross-immunity plays in shaping the
evolutionary and epidemiological dynamics of multi-strain pathogens (Gjini et al. 2016;
Zhang et al. 2013). Changes in cross-immunity are known to give rise to complex temporal
dynamics in disease incidence, and create oscillating time series from which it is difficult
to estimate parameters that govern the underlying epidemiological processes (Reich et al.
2013; Bhattacharyya et al. 2015). Studies about relationship between influenza and RSV
are predominantly qualitative (Pinky and Dobrovolny 2016; Bhattacharyya et al. 2015;
Gro¨ndahl et al. 2014). Though cross-immunities have been estimated for pathogens such
as dengue (Reich et al. 2013) and influenza and pneumococcal pneumonia (Shrestha et al.
2013), to our knowledge, there have been no quantitative studies of cross-interference
between influenza and RSV. Furthermore, to our knowledge, our work is the first to estimate
cross-immunity parameters for an SKM.
The flexibility of our model to capture multiple epidemic peaks is useful. For example,
Osthus et al. (2019) point out that a deterministic SIR model is restricted as to the number
of peaks it can capture within a single season, and a dynamic discrepancy model is required
to overcome this misspecification. As our model is stochastic, the posterior trajectories can
indeed have multiple peaks. The background model we selected is purposely independent
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of the influenza-RSV dynamics, but its flexibility is restricted to avoid confounding with
the observation error process and to avoid over-fitting.
In future work we plan to address several questions. First, we believe that accounting for
vaccination effects and seasonal forcing will yield additional insight into the interaction of
these two pathogens. However, estimation of these additional model components will likely
require the use of additional sources of data, such as vaccination reports and local climate
variables collected in the state. Secondly, our analysis agrees with the fact that multiple
strains of both influenza and RSV circulate during each year. Indeed, the emergence of very
virulent strains, such as in April of 2009, is not suitably captured by our model in which
parameters are essentially shared between strains of a single pathogen within each year.
Therefore, modeling such strains as separate pathogens may yield better understanding of
the circulation of ARI in the state.
These results can be of great use in epidemiological analyses that are carried out
to estimate the burden of influenza on morbidity and mortality at local, national, or
regional levels. Most current estimates of influenza-associated morbidity and mortality
do not take into account the contribution of RSV to excess mortality, due mainly to the
scarcity of virological surveillance information for all relevant viruses to incorporate in
these analysis. Our findings provide evidence that maintaining a sentinel program, by
administering virological tests at a clinical referral center, allows for reliable tracking of
virus circulation time at the population level at a relatively low cost. Our analysis shows
that even a relatively small number of such virological tests, when administered to all the
patients in a particular group can help to provide information about patterns of pathogen
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circulation.
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7 APPENDIX
Algorithm 1: Approximate SMC algorithm targeting (15) for fixed (θ, τ)
Define the augmented state vector X˜ = [X>, D]> and observation vector G˜ = [G>, 1]>. Define the
matrix V˜i =
[
Vi 0
0 V di
]
initialized with V0 = Ωc0Idim(X),dim(X) and V d0 = Ω3/2κ. Define the vector
m˜i = [mi,m
d
i ]
> initialized with m0 = x>1 and m
d
0 = Ωc. Compute prior marginal likelihood:
pa(y1 | θ, τ) = N
(
y1; rG˜
>m˜0, r2G˜>V˜0G˜+ Ω2Σ
)
The analysis distribution at time t = 1 is p (x˜1 | y1) = N
(
x˜1; m˜1, V˜1
)
where
m˜1 = m˜0 + rG˜
>V˜0(rG˜T V˜0G˜+ Ω2Σ)−1
(
y1 − rG˜T m˜0
)
V˜1 = V˜0 − r2G˜>V˜0(r2G˜>V˜0G˜+ Ω2Σ)−1V˜0G˜
for i=1, . . . ,M − 1 do
Integrate equations (4) and (9) from time ti to ti+1 using as initial conditions φi = mi/Ω and
Ci = Vi/Ω, to obtain φi+1 and Ci+1. Augment φ˜i+1 = [φ
>
i+1, c+m
d
i ]
> and
C˜i+1 =
[
Ci+1 0
0 Ω1/2κ
]
. The filtering distribution of X˜ is:
pa (x˜i+1 | yi) = N
(
x˜i+1; Ωφ˜i+1,ΩC˜i+1
)
Compute the marginal likelihood of Yi+1:
pa(yi+1 | θ, τ) = pa (yi | θ, τ) pa (yi+1 | y1:i)
where, pa (yi+1 | y1:i) = N
(
yi+1; rΩG˜
>φ˜i+1, r2ΩG˜>C˜i+1G˜+ Ω2Σ
)
The approximate analysis distribution at time ti+1 is pa (x˜i+1 | y1:i+1) = N
(
x˜i+1; m˜i+1, V˜i+1
)
where
m˜i+1 = Ωφi+1 + rΩG˜
>C˜0(rΩG˜T C˜i+1G˜+ Ω2Σ)−1
(
yi+1 − rΩG˜Tφi+1
)
V˜i+1 = ΩC˜i+1 − r2Ω2G˜>C˜i+1(r2ΩG˜>C˜i+1G˜+ Ω2Σ)−1C˜i+1G˜
Backward recursion, together with the approximation used to obtain the analysis distribution
above leads to a smoothing distribution for X˜1:M equal to the approximate analysis distribution:
pa (x˜1:M | y1:M ) = N
(
x˜1:M ; m˜1:M , V˜1:M
)
Sample a realization of x˜1:M = [x1:M , d1:M ] from pa (x˜1:M | y1:M ) and compute the likelihood
component p (n1:M | x1:M , d1:M , y1:M , θ, τ) from (14).
Return the product pa (y1:M | θ, τ) p (n1:M | x1:M , d1:M , y1:M , θ, τ) together with associated sample
path x˜1:M .
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8 SUPPLEMENTARY MATERIALS
Supplementary Material: “Inference for stochastic kinetic models from multiple data
sources for joint estimation of infection dynamics from aggregate reports and virological
data”. This document contains details of the equations and matrix specification, as
well as posterior summaries for the analysis of the real data and the simulations.
(pdf)
Python code: All software has been uploaded for review purposes (GNU zipped tar file).
Upon publication the code used to carry out the analysis will be provided online
Data: All data has been uploaded for review purposes (GNU zipped tar file) and will be
made available as described in the JASA ACS Author Form.
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virological data
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1 MODEL
This section provides mathematical details for the two-pathogen SIR model considered
in the paper “Inference for stochastic kinetic models from multiple data sources for joint
estimation of infection dynamics from aggregate reports and virological data”.
∗These authors contributed equally
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1.1 Chemical Master Equation
We define a stochastic SIR model for two pathogens following Kamo and Sasaki (2002).
Let,
X(t) = [XSS(t), XIS(t), XRS(t), XSI(t), XRI(t), XSR(t), XIR(t)]
>,
where Xkl(t) denotes the number of individuals at time t in immunological status k ∈
{S, I, R} for pathogen 1 (influenza) and immunological status l ∈ {S, I, R} for pathogen
2 (RSV). Vector x(t) corresponds to the realization of the random vector X(t). Reactions
associated with these events are listed in Table 1, where λ1 = (xis+xir)/Ω is the proportion
of individuals infected with pathogen 1, and λ2 = (xsi + xri)/Ω is the proportion infected
with pathogen 2. The number of possible reaction is R = 17. The evolution of the
probability distribution of finding the system in state x at time t is governed by the master
equation,
dpx(t)
dt
=
R∑
i1
ai(x− vi)px−vi(t)−
R∑
i=1
ai(x)px(t), (1)
where vi is the stoichiometric vector and ai is the rate of reaction i = 1, . . . , 17.
1.2 Large Volume Approximation
The van Kampen expansion (Van Kampen 1992) provides a large volume approximation
to the solution of the master equation that is made up of two terms, as follows:
X(t) = Ωφ(t) + Ω1/2ξ(t), (2)
2
Table 1: All possible reactions in the system; vi is the stochiometric vector, and ai(x) is
the propensity for the ith reaction, i = 1, . . . , 17.
Reactions Propensity Stoichiometric vector
µ→ XSS a1(x) = µΩ + o(∆t) v1 = [1, 0, 0, 0, 0, 0, 0, 0]
XSS → XSI a2(x) = β2λ2xss + o(∆t) v2 = [−1, 0, 0, 1, 0, 0, 0, 0]
XSS → XIS a3(x) = β1λ1xss + o(∆t) v3 = [−1, 1, 0, 0, 0, 0, 0, 0]
XSS → µ a4(x = µxss + o(∆t) v4 = [−1, 0, 0, 0, 0, 0, 0, 0]
XIS → µ a5(x) = µxis + o(∆t) v5 = [0,−1, 0, 0, 0, 0, 0, 0]
XIS → XRS a6(x) = γxis + o(∆t) v6 = [0,−1, 1, 0, 0, 0, 0, 0]
XRS → µ a7(x) = µxrs + o(∆t) v7 = [0, 0,−1, 0, 0, 0, 0, 0]
XRS → XRI a8(x) = σβ2λ2xrs + o(∆t) v8 = [0, 0,−1, 0, 1, 0, 0, 0]
XSI → XSR a9(x) = γxsi + o(∆t) v9 = [0, 0, 0,−1, 0, 1, 0, 0]
XSI → µ a10(x) = µxsi + o(∆t) v10 = [0, 0, 0,−1, 0, 0, 0, 0]
XRI → XRR a11(x) = γxri + o(∆t) v11 = [0, 0, 0, 0,−1, 0, 0, 1]
XRI → µ a12(x) = µxri + o(∆t) v12 = [0, 0, 0, 0,−1, 0, 0, 0]
XSR → µ a13(x) = µxsr + o(∆t) v13 = [0, 0, 0, 0, 0,−1, 0, 0]
XSR → XIR a14(x) = σβ1λ1xsr + o(∆t) v14 = [0, 0, 0, 0, 0,−1, 1, 0]
XIR → µ a15(x) = µxir + o(∆t) v15 = [0, 0, 0, 0, 0, 0,−1, 0]
XIR → XRR a16(x) = γxir + o(∆t) v16 = [0, 0, 0, 0, 0, 0,−1, 1]
XRR → µ a17(x) = µxrr + o(∆t) v17 = [0, 0, 0, 0, 0, 0, 0,−1]
where φ(t) describes macroscopic behavior and ξ is the noise term representing the aggregate
effects of demographic stochasticity on the system and describing its fluctuations. We make
an expansion in the powers of Ω (Van Kampen 1992) and collect powers of Ω1/2 to get the
macroscopic law given by the initial value problem,

dφi(t)
dt
=
∑R
j=1 Sijaj(φ(t)), t ∈ (0, T ], i = 1, . . . , dim{X(t)},
φi(0) = φ0, i = 1, . . . , dim{X(t)}.
(3)
3
Here S = [v1, . . . , vR] is the stoichiometric matrix and a(φ) = [a1(φ), . . . , aR(φ)] is the
vector of propensities. The full expressions for the macroscopic equations in the first line
of (3) are:
dφ0(t)
dt
= µ− β2λ2φ0 − β1λ1φ0 − µφ0,
dφ1(t)
dt
= β1λ1φ0 − γφ1 − µφ1,
dφ2(t)
dt
= γφ1 − σ2β2λ2φ2 − µφ2,
dφ3(t)
dt
= β2λ2φ0 − γφ3 − µφ3,
dφ4(t)
dt
= σ2β2λ2φ2 − γφ4 − µφ4,
dφ5(t)
dt
= γφ3 − µφ5 − σ1β1λ1φ5,
dφ6(t)
dt
= −γφ6 + σ1β1λ1φ5 − µφ6,
dφ7(t)
dt
= γφ6 + γφ4 − µφ7.
(4)
The stochastic process ξ is governed by the Itoˆ diffusion equation,
dξ(t) = A(t)ξ(t)dt+
√
B(t)dW (t), t ∈ [0, T ], (5)
W (t) denotes theR dimensional Wiener process. MatrixA(t) is given byA(t) = ∂S a(φ(t))
∂φ(t)
,
and matrix B(t) by B = Sdiag (a(φ))ST (Van Kampen 1992; Gillespie 2007). Expressions
for both matrices are provided in Table 2.
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2 NUMERICAL RESULTS
This section provides posterior summaries and pairwise correlation plots from the analysis of
real data (tables) and simulated data (figures) for each of the six epidemic years 2003-04 to
2008-09. The analysis was implemented Python. Python module “corner” (Foreman-Mackey
2016) used to display the bivariate posterior correlation plots.
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Figure 1: Posterior summaries for aggregated ARI reports from simulated data. The aggregated data,
measured from August to July of the following year, is represented by black dots. Grey bands represent
point-wise 95% credible intervals and the cyan dotted line shows a maximum a-posteriori estimated
trajectory.
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Figure 2: Posterior summaries for disaggregated reports based on simulated data. Left axis: Grey bands
represent 95% credible intervals for influenza (red outline), RSV (blue outline) and background infections
(green outline). Dotted lines represent maximum a-posteriori estimated trajectories. Right axis: Reports
of influenza and RSV from ARI affected children under 5 years of age at Hospital Central, with tests
positive for influenza, RSV, and neither, are shown as shaded red, blue, and green polygons, respectively.
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August 2003 - July 2004
Table 3: Posterior summaries for the year 2003-04
Parameter MAP 95% CIs Parameter MAP 95% CIs
β1 82.888 (68.336, 84.998) XSS 2281950 (2272925, 2316750)
β2 68.611 (52.863, 60.567) XIS 112 (6, 1646)
σ1 0.55731 (0.062984, 3.8505) XRS 42207 (27147, 70475)
σ2 1.8026 (1.6379, 2.3865) XSI 120 (982, 8988)
C0 1.1532e-04 (2.1151e-04, 1.4881e-02) XRI 153 (705, 8590)
Σ 6.2585e-07 (4.5941e-07, 5.9472e-07) XSR 27767 (1298 26482)
r 0.07439 (0.07873, 0.09002) XIR 260 (21, 1214)
c 0.03758 (0.03185, 0.03435) XRR 147422 (119542, 160572 )
ν 0.2002 (0.20092, 0.20318)
v 0.1040 (0.1016, 0.10309)
Figure 3: Analysis based on simulated data. Pairwise marginal contours for the parameters defining the
stochastic kinetic model. Blue lines represent the values of the simulation parameters for comparison.
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Figure 4: Analysis based on simulated data. Pairwise marginal contours for the initial conditions (left)
and the auxiliary parameters (right). Blue lines represent the values of the simulation parameters for
comparison.
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August 2004 - July 2005
Table 4: Posterior summaries for the year 2004-05
Parameter MAP 95% CIs Parameter MAP 95% CIs
β1 64.3754 (50.2483, 71.1815) XSS 2281352 (2252426, 2284653)
β2 68.3774 (58.2333, 69.3508) XIS 397 (45, 3809)
σ1 1.4021 (0.4856, 3.2505) XRS 39800 (32530, 41698)
σ2 1.5325 (0.5249, 6.5877) XSI 1880 (121, 9308)
C0 8.8445e-03 (8.8445e-03, 1.6631e-02) XRI 2125 (84, 4770)
Σ 2.3857e-07 (2.0714e-07, 3.7927e-07) XSR 30237 (20542, 45622)
r 0.1035 (0.1009, 0.1275) XIR 455 (46, 13053)
c 0.02456 (0.02207, 0.02692) XRR 143751 (140067, 159271)
ν 0.1994 (0.1994, 0.2016)
v 0.0996 (0.09621, 0.09985)
Figure 5: Analysis based on simulated data. Pairwise marginal contours for the parameters defining the
stochastic kinetic model. Blue lines represent the values of the simulation parameters for comparison.
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Figure 6: Analysis based on simulated data. Pairwise marginal contours for the initial conditions (left)
and the auxiliary parameters (right). Blue lines represent the values of the simulation parameters for
comparison.
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August 2005 - July 2006
Table 5: Posterior summaries for the year 2005-06
Parameter MAP 95% CIs Parameter MAP 95% CIs
β1 42.0182 (29.6829, 70.7165) XSS 2280677 (2260296, 2308459)
β2 60.8559 (57.2093, 64.5793) XIS 172 (60, 8445)
σ1 1.433 (0.8806, 2.4955) XRS 52842 (46354, 65694)
σ2 3.1773 (1.5288, 4.8721) XSI 523 (17, 10064)
C0 2.1307e-03 (2.1264e-03, 2.0333e-02) XRI 10998 (458, 9972)
Σ 3.4695e-07 (2.3463e-07, 4.0426e-07) XSR 8511 (5143, 34599)
r 0.07464 (0.07464, 0.1026) XIR 3294 (121, 6687)
c 0.03248 (0.02310 0.03248) XRR 142980 (89822, 147742)
ν 0.2030 (0.1986, 0.2037)
v 0.0996 (0.0991, 0.1007)
Figure 7: Analysis based on simulated data. Pairwise marginal contours for the parameters defining the
stochastic kinetic model. Blue lines represent the values of the simulation parameters for comparison.
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Figure 8: Analysis based on simulated data. Pairwise marginal contours for the initial conditions (left)
and the auxiliary parameters (right). Blue lines represent the values of the simulation parameters for
comparison.
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August 2006 - July 2007
Table 6: Posterior summaries for the year 2006-07
Parameter MAP 95% CIs Parameter MAP 95% CIs
β1 65.0052 (51.6991, 72.5779) XSS 2283027 (2276015, 2283448)
β2 65.9325 (59.1039, 72.71007) XIS 253 (22, 4565)
σ1 1.2071 (0.7281, 2.9201) XRS 40492 (32380 , 44181)
σ2 1.9023 (1.7082, 5.7772) XSI 1072 (529, 2642)
C0 9.1189e-03 (9.7820e-03, 1.0184e-02) XRI 98 (228, 4203)
Σ 2.8170e-07 (2.5109e-07, 3.0907e-07) XSR 27489 (22628, 29628)
r 0.3452 (0.08717, 0.1061) XIR 69 (33, 6063)
c 7.6224e-03 (2.5762e-03 2.8315e-02) XRR 147496 (142788, 149660)
ν 0.1999 (0.1999, 0.2000)
v 0.10005 (0.1000, 0.1001)
Figure 9: Analysis based on simulated data. Pairwise marginal contours for the parameters defining the
stochastic kinetic model. Blue lines represent the values of the simulation parameters for comparison.
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Figure 10: Analysis based on simulated data. Pairwise marginal contours for the initial conditions (left)
and the auxiliary parameters (right). Blue lines represent the values of the simulation parameters for
comparison.
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August 2007 - July 2008
Table 7: Posterior summaries for the year 2007-08
Parameter MAP 95% CIs Parameter MAP 95% CIs
β1 44.6873 (42.3106, 64.1864) XSS 2285503 (2275957, 2284394)
β2 74.3809 (68.8012, 77.8589) XIS 3834 (12, 4641)
σ1 3.2271 (1.6241, 3.9189) XRS 34692 (35888, 51149)
σ2 3.2649 (2.2319, 4.0325) XSI 1954 (403, 3944)
C0 2.8743e-03 (8.3868e-03, 1.1844e-02) XRI 2187 (244, 7374)
Σ 3.3520e-07 (2.5413e-07, 4.9473e-07) XSR 26974 (14239, 28792)
r 0.06622 (0.057711, 0.07034) XIR 200 (41, 2493)
c 0.04461 (0.038592, 0.04900) XRR 144657 (141853, 151902)
ν 0.2130 (0.20471, 0.2579)
v 0.1478 (0.10015, 0.1312)
Figure 11: Analysis based on simulated data. Pairwise marginal contours for the parameters defining
the stochastic kinetic model. Blue lines represent the values of the simulation parameters for comparison.
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Figure 12: Analysis based on simulated data. Pairwise marginal contours for the initial conditions (left)
and the auxiliary parameters (right). Blue lines represent the values of the simulation parameters for
comparison.
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August 2008 - July 2009
Table 8: Posterior summaries for the year 2008-09
Parameter MAP 95% CIs Parameter MAP 95% CIs
β1 22.69446 (47.4071, 72.6521) XSS 2218862 (2282264, 2352741)
β2 65.7909 (61.7720, 69.6492) XIS 1530 (51, 4964)
σ1 1.1189 (0.8197, 2.8442) XRS 171391 (21190 , 42842)
σ2 0.7311 (1.7682, 12.3335) XSI 2758 (777, 7972)
C0 5.6218e-02 (7.0720e-03, 1.2263e-02) XRI 4421 (291, 3925)
Σ 3.1020e-06 (2.0303e-06, 3.9120e-06) XSR 13593 (11606, 26648)
r 0.1042 (0.1077, 0.1609) XIR 3729 (8, 3539)
c 0.02627 (0.021435,0.02944) XRR 83717 (94793 , 147809)
ν 0.1673 (0.1984, 0.1994)
v 0.2174 (0.08485, 0.09923)
Figure 13: Analysis based on simulated data. Pairwise marginal contours for the parameters defining
the stochastic kinetic model. Blue lines represent the values of the simulation parameters for comparison.
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Figure 14: Analysis based on simulated data. Pairwise marginal contours for the initial conditions (left)
and the auxiliary parameters (right). Blue lines represent the values of the simulation parameters for
comparison.
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